Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular testing in solid tumors: an overview.

Jennifer L Hunt1

  • 1Department of Anatomic Pathology, L25, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA. huntj2@ccf.org

Archives of Pathology & Laboratory Medicine
|February 7, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Some Considerations on the WHO Histological Classification of Laryngeal Neoplasms.

Advances in therapy·2019
Same author

Well-differentiated Neuroendocrine Carcinoma of the Larynx: Confusion of Terminology and Uncertainty of Early Studies.

Advances in anatomic pathology·2019
Same author

Salivary myoepithelial cells: an addendum.

Ultrastructural pathology·2018
Same author

Data Set for the Reporting of Nodal Excisions and Neck Dissection Specimens for Head and Neck Tumors: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting.

Archives of pathology & laboratory medicine·2018
Same author

Structural biology of intraepithelial neuroendocrine cells in the larynx: Literature review.

Pathology, research and practice·2018
Same author

Surgical margins in head and neck cancer: Intra- and postoperative considerations.

Auris, nasus, larynx·2018
Same journal

Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.

Archives of pathology & laboratory medicine·2026
Same journal

Cross-Reactivity of TPIT Antibody Clone OTI2G1 in Chordoma: Structural Mechanisms and Diagnostic Implications.

Archives of pathology & laboratory medicine·2026
Same journal

Paracoccidioidomycosis at Autopsy: A Case Series and Literature Review.

Archives of pathology & laboratory medicine·2026
Same journal

Accuracy of Cytology Diagnosis for Well Differentiated Neuroendocrine Tumors: Assessment by the College of American Pathologists Non-Gynecologic Slide Program.

Archives of pathology & laboratory medicine·2026
Same journal

Serum Immunofixation Electrophoresis Guidance Conflict: A Call to Harmonize.

Archives of pathology & laboratory medicine·2026
Same journal

In Reply.

Archives of pathology & laboratory medicine·2026
See all related articles

Molecular testing is crucial in anatomic pathology for cancer diagnosis and treatment. Pathologists must understand available assays for thyroid, oligodendroglioma, and lung cancers to identify standard of care methods.

Area of Science:

  • Pathology
  • Molecular Diagnostics
  • Oncology

Background:

  • Molecular testing is increasingly vital in anatomic pathology.
  • Accurate interpretation of molecular assays aids in cancer diagnosis, prognosis, and therapy response prediction.
  • Anatomic pathologists must distinguish between standard and non-standard molecular assays.

Purpose of the Study:

  • To review key molecular assays for common tumor types.
  • To discuss the clinical utility of these assays in pathology.
  • To highlight emerging molecular diagnostic tools.

Main Methods:

  • Review of current and emerging molecular assays.
  • Analysis of specific molecular markers for thyroid cancer (RET-PTC, PPARgamma-PAX8 translocations).

Related Experiment Videos

  • Discussion of molecular testing in oligodendroglioma (1p/19q loss) and lung carcinoma (BRAF, EGFR mutations).

    • Main Results:

    • Specific molecular alterations are discussed for thyroid cancer, oligodendroglioma, and lung carcinoma.
    • These include translocation analyses, point mutation analyses, and genetic loss detection.
    • The relevance of these tests for clinical decision-making is emphasized.

    Conclusions:

    • Molecular testing is essential for the future of anatomic pathology.
    • Understanding specific molecular assays is critical for pathologists.
    • Distinguishing standard of care tests is key for effective cancer management.